期刊文献+

靶向PTTG和survivin双干扰siRNA表达载体的构建及鉴定

Construction and identification of double interference vector targeting both PTTG and survivin gene
下载PDF
导出
摘要 目的:构建同时干扰人垂体瘤转化基因(PTTG)和生存素(survivin)基因表达的RNA共干扰载体,并检测其对人脑胶质瘤U251细胞中PTTG基因和survivin基因的干扰作用。方法:根据GenBank数据库中PTTG和survivin的cDNA序列设计干扰序列,构建干扰PTTG和生存素基因的重组干扰质粒pGenesil-2.1-PTTG siRNA和pGenesil-2.1-survivin siRNA。酶切、测序鉴定正确后,将pGenesil-2.1-Survivin和pGenesil-2.1-PTTG质粒分别进行HindⅢ和BamHⅠ双酶切,1%琼脂糖凝胶电泳分别回收质粒survivin双酶切大片段和质粒PTTG双酶切小片段(约380bp),将质粒survivin回收大片段与质粒PTTG回收小片段进行连接,得到双干扰质粒pGenesil-2.1-PTTG-survivin siRNA,酶切鉴定,同时检测其对U251细胞PTTG和survivin基因mRNA表达的干扰作用。结果:测序和酶切鉴定结果显示,pGenesil1-PTTG、pGenesil1-survivin和双干扰质粒pGenesil2.1-PTTG-survivin siRNA构建正确;RT-PCR结果显示,将双干扰质粒转染U251细胞48h后,U251细胞中PTTG基因和survivin基因mRNA表达明显降低。结论:成功构建了能同时干扰PTTG和survivin基因的双干扰pGenesil1-PTTG-Survivin siRNA表达载体,并可有效抑制U251细胞PTTG和srvivin基因mRNA的表达。 Objective To construct the double interference vector targeting both PTTG and survivin gene and detect its silencing effects on PTTG and survivin gene in human glioma U251 cell line.Methods Two effective targeting sequences were chosen according to PTTG and survivin cDNA sequences in GenBank,then they were inserted into pGenesil-2.1 vector and pGenesil-2.1-PTTG and pGenesil-2.1-survivin plasmids were constructed.The recombinant plasmids were identified by restriction endonuclease and DNA sequencing.pGenesil-2.1-survivin and pGenesil-2.1-PTTG plasmids were digested by HindⅢ and BamHⅠ separately,long fragment of pGenesil-2.1-survivin plasmid and small fragment of pGenesil-2.1-PTTG(about 380 bp) were collected by 1% agarose gel electrophoresis.The double interference vector pGenesil-2.1-PTTG-survivin siRNA was constructed by uniting long fragment of pGenesil-2.1-srvivin plasmid and small fragment of pGenesil-2.1-PTTG.This plasmid was identified by restriction enzyme digestion and then its silencing effects on PTTG and surviving gene were detected.Results By restriction endonuclease and DNA sequencing,the eukyaryotic expression plasmid of pGenesil-2.1-PTTG,pGenesil-2.1-survivin and pGenesil-2.1-PTTG-survivin siRNA were constructed correctly.The result of RT-PCR showed that PTTG and survivin gene mRNA levels were decreased obviously after this plasmid was transfected into U251 cells for 48 h.Conclusion pGenesil-2.1-PTTG-survivin siRNA plasmid is constructed successfully.The PTTG and survivin gene mRNA levels in U251 cells are decreased effectively by transfecting this plasmid into U251 cells.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2011年第6期1028-1032,1175,共6页 Journal of Jilin University:Medicine Edition
基金 教育部博士点基金资助课题(20070183193) 吉林省科技厅自然科学基金资助课题(200705108)
关键词 垂体肿瘤转化基因 生存素 RNA干扰 胶质瘤 pituitary tumor transforming gene survivin RNA interference glioma
  • 相关文献

参考文献12

  • 1徐松柏,赵刚,赵红光,许侃,于洪泉,夏常丽,康淑红.PTTG靶向siRNA表达载体构建及其沉默效率评价[J].吉林大学学报(医学版),2008,34(3):411-414. 被引量:2
  • 2Katsuyuki Shirai,Yoshiyuki Suzuki,Kuniyuki Oka,Shin-ei Noda,Hiroyuki Katoh,Yoshihiko Suzuki,Jun Itoh,Hideaki Itoh,Shogo Ishiuchi,Hideyuki Sakurai,Masatoshi Hasegawa,Takashi Nakano.Nuclear survivin expression predicts poorer prognosis in glioblastoma[J]. Journal of Neuro - Oncology . 2009 (3)
  • 3Tfelt-Hansen J.The role of calcium-sensing receptor andsignalling pathways in the pathophysiology in two in vitromodels of malignant hypercalcemia:the rat rice H-500Leydigtestis cancer and prostate cancer(PC-3)cells.Expression andregulation of pituitary tumor transformi. Dan MedBull . 2008
  • 4Chintharlapalli S,Papineni S,Lee SO,et al.Inhibition ofpituitary tumor-transforming gene-1in thyroid cancer cells bydrugs that decrease specificity proteins. Molecular Carcinogenesis . 2011
  • 5Sioud M.Promises and challenges in developing RNAi as aresearch tool and therapy. Methods in Molecular Biology . 2011
  • 6Zhen HN,Li LW,Zhang W,et al.Short hairpin RNAtargeting survivin inhibits growth and angiogenesis of gliomaU251cells. International Journal of Oncology . 2007
  • 7Miyagishi M,Taira K.U6 promoter-driven siRNAs with four uridine 3’ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnology . 2002
  • 8Paddison P J,Caudy A A,Hannon G J.Stable suppression of gene expression by RNAi in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America . 2002
  • 9Chao JI,Liu HF.The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells. Molecular Pharmacology . 2006
  • 10Chamaon K,Kirches E,Kanakis D, et al.Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes. Biochemical and Biophysical Research Communications . 2005

二级参考文献12

  • 1Pei L, Melmed S. Isolation and characterization of a pituitary tumor transforming gene (PTTG) [J]. Mol Endoerinol, 1997, 11 (4): 433-441.
  • 2de la Torre NG, Turner HE, Wass JA. Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour [J]. Pituitary, 2005, 8 (1):17-23.
  • 3Tsai SJ, Lin SJ, Cheng YM, et al. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas [J]. J Clin Endocrinol Metab, 2005, 90 (6): 3715-3723.
  • 4Genkai N, Homma J, Sano M, et al. Increased expression of pituitary tumor-transforming gene (PTTG) 1 is eorrelated with poor prognosis in glioma patients [J]. Oncol Rep, 2006, 15 (6): 1569-1574.
  • 5Hassan A. Potential applications of RNA interference-based therapeutics in the treatment of cardiovascular disease [J]. Recent Patents Cardiovasc Drug Discov, 2006, 1 (2) : 141- 149.
  • 6Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies [J]. Expert Rev Mol Diagn, 2008, 8 (1): 29-39.
  • 7Haney SA. Expanding the repertoire of RNA interference screens for developing new anticancer drug targets [J]. Expert OpinTherTargets, 2007, 11 (11): 1429-1441.
  • 8Yu AM. Small interfering RNA in drug metabolism and transport [J]. Curr Drug Metab, 2007, 8 (7) : 700-708.
  • 9Khoury M, Jorgensen C, Apparailly F. RNAi in arthritis: prospects of a future antisense therapy in inflammation [J]. Curr Opin Mol Ther, 2007, 9 (5):483-489.
  • 10Gonzalez-Alegre P, Paulson HL. Technology insight:therapeutic RNA interference-how far from the neurology clinic? [J]. Nat Clin Pract Neurol, 2006, 3 (7): 394-404.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部